AseptiScope Announces that Data Presented at October Medical Congresses Support the Use of Aseptic Disk Covers to Protect Against Contaminated Stethoscopes
Dr. Frank Peacock, a co-founder of AseptiScope and a co-author of the study featured at the IDSA entitled Effectiveness of Aseptic Stethoscope Barriers in Allowing Clean Contact for Clostridioides Difficile-Contaminated Stethoscope, commented "this important study builds on a body of data supporting the use of aseptic disk covers to protect patients from exposure to pathogens on the stethoscope.
SAN DIEGO, Oct. 22, 2020 /PRNewswire-PRWeb/ -- AseptiScope™ Inc., a privately funded San Diego, California based clinical innovation company announced today that a study describing the challenge of stethoscope hygiene practices and two studies supporting the use of aseptic disk covers to protect patients from exposure to pathogens on the stethoscope diaphragm are featured at medical conferences in October.
Dr. Frank Peacock, a co-founder of AseptiScope and a co-author of the study featured at the IDSA entitled Effectiveness of Aseptic Stethoscope Barriers in Allowing Clean Contact for Clostridioides Difficile-Contaminated Stethoscope, commented "this important study builds on a body of data supporting the use of aseptic disk covers to protect patients from exposure to pathogens on the stethoscope. By now demonstrating that disk covers are an effective barrier against alcohol-resistant C. difficile spores, we have established the relevance of our solution against one of the most prominent and challenging drug-resistant superbugs that healthcare faces today," Dr. Peacock added.
"We are pleased to see these two prestigious congresses focus on the longstanding challenge of stethoscope hygiene," said Scott Mader the CEO and co-founder of AseptiScope. "The findings further substantiate the stethoscope contamination challenge while supporting the use and effectiveness of touch-free, aseptic, single-use stethoscope disk covers. With the upcoming launch of our flagship product, The DiskCover™ System, we look forward to bringing important innovation to this market," he added.
The details of the data presentations are as follows:
Infectious Disease Society of America IDWeek Virtual Meeting (https://idweek.org)
Poster Name: Effectiveness of Aseptic Stethoscope Barriers in Allowing Clean Contact for Clostridioides Difficile-Contaminated Stethoscope
Poster Session: HAI: Disinfection/Sterilization & Environmental Infection Prevention
Poster Number: 816
Presenter: Rajiv S. Vasudevan, BS
Date: On-Demand as of 21 October 2021
American College of Emergency Physicians Annual Meeting ACEP20 (https://www.acep.org/sa/)
Poster Name: Stethoscope Cleaning Practices and Knowledge Amongst Healthcare Providers
Track: Research
Poster Number: 255
Presenter: Sarathi Kalra, MD
Date: On-Demand as of 26 October 2020
Poster Name: Are Stethoscopes and Infection Control Enemies?
Track: Research
Poster Number: 257
Presenter: Sarathi Kalra, MD
Date: On-Demand as of 26 October 2020
About AseptiScope, Inc.
AseptiScope, formed in early 2016, is a privately funded San Diego, California based, clinical innovation company. The company is founded and led by clinical innovation experts, leading medical researchers and practicing physicians. The AseptiScope mission is to design, develop, manufacture and commercialize novel solutions that ensure "Infection Protection for Clinician & Patient." The company will introduce the first true and practical solution for the longstanding challenge of stethoscope contamination in autumn of 2020: The DiskCover System™. Visit https://aseptiscope.com for more information.
AseptiScope, DiskCover, and related logos are trademarks of AseptiScope, Inc.
SOURCE AseptiScope, Inc.
